Aytu BioScience's total assets for Q4 2026 were $105.01M, a decrease of -5.98% from the previous quarter. DE:AY20 total liabilities were $69.73M for the fiscal quarter, a -8.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.